Accelerating Australia’s Perth Biodesign program is well underway with teams having completed clinical immersions in Perth’s major hospitals and now focusing in on their selected unmet clinical need.
The Perth Biodesign launch took place at CERI on the 28 March 2018. Featuring keynote speaker Dr Fiona Wood along with former guest speakers, mentors, stakeholders and alumni to celebrate the achievements of previous years and launch into a new year of the Biodesign course.
Perth Biodesign is a six-month course that brings together participants from a variety of disciplines to develop solutions for unmet medical needs. Teams include scientists, doctors, engineers, business people, clinicians and researchers, who observe a GP surgery or emergency department and identify where there is a gap.
Their task is to then create a solution to the problem, such as a new medical device, digital health solution or algorithm, and through the six month program they validate their need, brainstorm solutions, create a prototype and implementation plan and, at the conclusion, are given the opportunity to put their idea to the test at the final pitch night.
Course directors Matthew Oldakowski and Intan Oldakowska, recently returned from Stanford University, where Matt was sponsored by CERI-based Accelerating Australia to undergo the Global Faculty in Training (GFIT) program. The GFIT program is designed to instruct experienced medtech innovators on the Biodesign process and how to teach it so that they may launch similar programs around the world. Whilst in Stanford, Matt’s own Biodesign team won the Robert Howard Next Step award for their device, EarBuddy, a non-invasive way to treat Otitis Media with Effusion, or “glue-ear”.
If you’re interested in creating an innovative solution for the medical sector here in WA, register your interest for Perth Biodesign 2019.